Clinical utility of array comparative genomic hybridization: uncovering tumor susceptibility in individuals with developmental delay.

Abstract excerpt

Microarray-based comparative genomic hybridization can determine genome-wide copy number alterations at the kilobase level. We highlight the clinical utility of microarray-based comparative genomic hybridization in determining tumor susceptibility in 3 patients with dysmorphic features and developmental delay, likely decreasing both morbidity and mortality in these patients.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to AMP-Activated Protein Kinase Kinases
• Share to Comparative Genomic Hybridization